Francisco J. Amador, MD

Maduro is NOT the President of Venezuela and his regime is NOT the legitimate government. Maduro is the head of the Cartel de Los Soles, a narco-terror organization which has taken possession of a country. And he is under indictment for pushing drugs into the United States.

@CryptoGhosty333 I like the facts you are pointing out… I want to hear more.

BTC Theory: 69-74K Fear Test, BULL Trap Bounce, Final Shakeout Below 50 SMA – Then Surge to 200K ATH by Q1 2027? In 2017, $BTC went down 83% from ATH. In 2021, BTC went down 73%. This time we could get around a 60% drop. This shows a clear trend of diminishing returns and losses. We can see on the monthly chart that in the past 2 bear cycles, we went below the 50 SMA. This potential 125k top is similar to the 2019 top due to the fact we didn't have a euphoric top... I took a measured move from the 2019 top until the next ATH, and it took around 450 days... If we take the same measured move from October 6, applying the same time frame, we should get a new ATH ending Q4 of 2026 or starting Q1 2027... We also have massive confluence around the 69k-74k range... also, I see it unlikely MSTR's average price isn't tested... I see us getting that level tested, creating fear, then we get a strong bounce... Then trap people that believe this cycle is extended and retest the 50SMA and reject on the weekly like we have in the past before our final flush down to our final target below the 50 SMA as history has shown get the final shakeout. Once the bull market resumes, we will head towards 155k, which is a key trendline as shown on the chart and beyond. Last lowest NAV price on MSTR was 0.7 in 2022... I expect we revisit similar levels...

Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction: @NEJM 🥸 Will the use of Aspirin decline overtime in ACS management? #ESCCongress2025 😱The TARGET-FIRST trial 👇👇👇

Congratulations to our @MSMEDU Cardiology fellow, Dr. Francisco Amador (@fjamadorc), on his #ACC25 poster presenting a case of aortic dissection masquerading as acute pericarditis. A reminder to follow clinical intuition when things don’t quite add up. @ACCinTouch @GradyHealth

Among individuals without significant CV morbidity younger than 50 years, the use of cannabis is 🔗 to adverse CV events. The 🔎 suggest cannabis as a novel & underrecognized risk factor for #CVD. Learn more & don't miss the presentation at #ACC25 ➡️ bit.ly/4203c3P

Cardiology trying to cross the ER without getting noticed.

Smoking-relevant parameters show strong and dose-response relationships across 3 domains of subclinical markers of cardiovascular harm. Read the journal scan to learn more: bit.ly/3DEMRJB #cvPrev @JACCJournals #JACC

🆕 2025 ACC/AHA/ACEP/NAEMSP/SCAI ACS Guideline highlights the importance of the most recent clinical evidence in treating patients w/ heart attacks and other #cvACS. Access the guideline here: bit.ly/41md07V @JACCJournals #ClinicalGuidelines #JACC

#SGLT2 inhibitors may slow the progression of nonsevere aortic stenosis, according to a study published in #JACCINT. Learn more: bit.ly/4hOrOmA #vhdAS #cvVHD @JACCJournals

La Colombia de hoy es muy diferente a la que prosperó bajo el liderazgo del expresidente @AlvaroUribeVel. El juicio farsa en curso, la persecución política y la cacería de brujas contra @AlvaroUribeVel reflejan el avance de fuerzas de extrema izquierda que controlan a @petrogustavo. @petrogustavo y sus aliados deben tener claro que Estados Unidos y los socios de la democracia colombiana siguen de cerca el desarrollo de estos hechos injustos. 
El uso politizado de los tribunales como herramienta de represalia es peligroso, perjudicial y profundamente anti-democrático. Es inaceptable.

Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation: @NEJM 🥸Summary 👇👇👇

Lipoprotein(a) is an independent predictor for long-term in-stent restenosis and should be considered in the evaluation of patients undergoing PCI. academic.oup.com/eurjpc/article… @escardio @AboyansV @SilCastelletti @PeroneFrancesco @andreagallardo #cvprev

This is real

🔥Fresh Press 🔥 We propose a novel candidate therapy for HFpEF. doi.org/10.1002/ejhf.3… @HFpEF @LitwinSheldon @KSharmaMD @MkosiborodMD @MidAmericaHeart @saintlukeskc

WHAT is goin on #cardionerds? 🤓 (sound on) Echo of the week #echofirst #cvimaging

Physical activity appears to reduce CV risk in part by acting through stress-related brain activity; this may contribute to the novel observation that physical activity reduces CV risk to a greater extent among individuals with #depression. bit.ly/4d0wrYT #JACC

Gearing up for Heart Failure Awareness Week 2024❣️ Join our Residents on February 14th, 2024 to talk about Heart Failure🫀 @MitchellHare @EBrennan9 @VictorFSMD @fjamadorc @Henryaiwuyo1 @NikolaS11775830 @AdarshGBalaji @ProfdotOlayemi @kikibebz

Does high-sensitivity C-reactive protein modulate the association between Lp(a) & coronary heart disease in the general population when defined as prevalent and incident events? Read the journal scan to learn more: bit.ly/3w4WGMC #cvPrev

This patient presented with syncope, then cardiac arrest (but no chest pain). She was resuscitated, but had no obstructive coronary disease on cath! — How to explain that no “culprit” artery was found on cath? — GO TO — tinyurl.com/KG-Blog-415 — #ECG - #ECG_Ken_Grauer - #EKG — :)

Holter ECG over 28 seconds; rhythm?